Search results
Stories of Hope: Jennifer Alexander
… Venezuela in 1991. As every immigrant, I went through lots of struggles but I was excited about the future and eager to better the life of my children. … and that’s when I said to myself that this type of cancer is more aggressive than the others and it will sure kill me. …
Last Modified:
Stories of Hope: John Whitley
… My name is John Whitley, and I have lived in Nyack for 25 years. In … Hospital. Many, many tests finally revealed that I was in the early stages of pancreatic cancer. On May 20, 2011, I underwent a … Stories of Hope: John Whitley …
Last Modified:
Stories of Hope: Ryan Finlay
… Ryan is a tough guy—a combat veteran and an NYPD cop. Once, on … Every doctor he saw had a different diagnosis. And none of them were able to help. Then he met with Dr. Amrita Sethi … Ryan’s pancreas would be placed in his liver, and then the failing pancreas would be removed. After 6 years on …
Last Modified:
Stories of Hope: Sylvia George
… diagnosed with advanced localized pancreatic cancer in May of 2017. It started with unexplained back pain, a vague … with her GP. After a CT scan found a spot on her pancreas, the biopsy then confirmed the diagnosis. Here, Sylvia took a … What would you like to share about your experience? What is the most important thing you learned through this process? …
Last Modified:
Stories of Hope: Regina Haimer
… started with my yearly routine visit to my OB/GYN in May of 2012. After my check-up, which was just fine, my doctor came back into the room and mentioned that there was a microscopic trace of … this large mass and recommended surgery. Dr. Dhar is also on the staff at NewYork-Presbyterian/Columbia (how …
Last Modified:
Flattening the Curve through Telehealth, and Beyond
… It’s time to bring back house calls. Not the kind where your doctor rings the doorbell carting a … bag; but access to your physician from the comfort of your home. Access that’s simple, direct, and virtual. … pandemic and a large step toward improving access to high-quality care irrespective of location—now and in the future. …
Last Modified:
The Inflammatory Bowel Disease Center at Columbia
… The IBD Center at Columbia is a dedicated team of inflammatory bowel disease specialists with years of … IBD but also has trained staff to help patients cope with their disease long-term. Nutrition : We provide nutritional … The Inflammatory Bowel Disease Center at Columbia …
Last Modified:
Phase II Open-Label, Single-Center Study Evaluating Safety and Efficacy of Pembrolizumab Following Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of First-Line Therapy
… Single-Center Study Evaluating Safety and Efficacy of Pembrolizumab Following Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of First-Line Therapy …
Last Modified:
A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 228 in Subjects with Selected Advanced Solid Tumors
… The purpose of this study is to find out more about the effects of AMG 228 in people that have advanced non-small … A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 228 in Subjects with Selected Advanced Solid Tumors …
Last Modified:
A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
… This trial will be comparing the Eluvia stent with the Zilver PTX stent in patients with chronic, symptomatic atherosclerosis of the lower extremities. The primary objective of this trial is to evaluate the safety and effectiveness of the ELUVIA … A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for …
Last Modified:
A Phase I/II Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
… The primary purpose of this research study is to test the effectiveness (how well the drug works), safety, and … A Phase I/II Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-CD27 …
Last Modified:
Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety, and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy (STOP-HE)
… The purpose of this study is to determine whether ornithine phenylacetate can speed … Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety, and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients …
Last Modified:
The Four Steps to Your Successful Transplantation
… you arrive for assessment at Columbia, you become part of an intensely personal, four-phase program designed to … you and your family through this challenging time. I - The Evaluation Phase Members of Columbia's transplant team … York region, most patients wait from 10 to 14 months for their replacement organ(s) to become available. During your …
Last Modified:
Pediatric Services at the Columbia Thyroid Center
… For children and their families dealing with thyroid disease, the Columbia Thyroid Center offers a healthcare team of pediatric endocrinologists, thyroid surgeons, … Pediatric Services at the Columbia Thyroid Center …
Last Modified: